BACKGROUND: Cannabidiol (CBD), a non-psychoactive cannabinoid increasingly used during pregnancy, has been proposed to modulate inflammatory processes. However, its effects on human placental immune functions remain poorly characterized. This study investigates the impact of CBD on lipopolysaccharide (LPS)-induced inflammation in human placenta explants and primary trophoblast cells, focusing on cytokine expression, receptor involvement, and underlying mechanisms. METHODS: Term placental explants and syncytiotrophoblast cells were exposed to LPS with or without CBD. Inflammatory cytokine levels were quantified by ELISA and RT-qPCR. Receptor involvement was assessed using selective antagonists for cannabinoid receptors type 1 and 2 (CB1 and CB2), and transient receptor potential cation channel subfamily V member 1 (TRPV1). NF-κB activation was evaluated by immunofluorescence, and caspase-1 activity was measured to explore inflammasome-related pathways. RESULTS: CBD significantly attenuated LPS-induced interleukin-1β (IL-1β), tumor necrosis factor alpha (TNF-α), interleukin 6 (IL-6), and interleukin 18 (IL-18) expression in a concentration-dependent manner, without inducing cytotoxicity. These effects were not reversed by CB1, CB2, or TRPV1 antagonists, indicating that other pathways are likely involved. CBD was associated with reduced NF-κB p65 nuclear translocation yet did not affect caspase-1 activity or transcript levels, indicating inflammasome-independent suppression. CONCLUSION: CBD exerts anti-inflammatory effects in human placenta and trophoblasts, associated with reduced NF-κB p65 nuclear translocation and independent of CB1, CB2, and TRPV1 signaling, without evidence of canonical inflammasome activation. Given the placenta's role in fetal programming, these findings underscore the importance of evaluating CBD's developmental impact in the context of its growing perinatal use.

Department of Biochemical Sciences Charles University Faculty of Pharmacy in Hradec Kralove Akademika Heyrovskeho 1203 Hradec Kralove Czech Republic

Department of Pharmacology and Toxicology Charles University Faculty of Pharmacy in Hradec Kralove Akademika Heyrovskeho 1203 Hradec Kralove 500 05 Czech Republic

Zobrazit více v PubMed

Alves P, Amaral C, Teixeira N, Correia-da-Silva G. Cannabidiol disrupts apoptosis, autophagy and invasion processes of placental trophoblasts. Arch Toxicol. 2021;95(10):3393–406. PubMed DOI

Ariyakumar G, Morris JM, McKelvey KJ, Ashton AW, McCracken SA. NF-kappaB regulation in maternal immunity during normal and IUGR pregnancies. Sci Rep. 2021;11(1):20971. PubMed DOI PMC

Aziz AI, Nguyen LC, Oumeslakht L, Bensussan A, Ben Mkaddem S. Cannabinoids as immune system modulators: cannabidiol potential therapeutic approaches and limitations. Cannabis Cannabinoid Res. 2023;8(2):254–69. PubMed

Barker DJ. The developmental origins of adult disease. J Am Coll Nutr. 2004;23(6 Suppl):588S-S595. PubMed DOI

Bathula PP, Maciver MB. Cannabinoids in treating chemotherapy-induced nausea and vomiting, cancer-associated pain, and tumor growth. Int J Mol Sci. 2023;25(1):74. PubMed DOI PMC

Berman E, Erenburg N, Beloosesky R, Eyal S, Kovo M. Placental disposition of cannabidiol: an ex vivo perfusion study. Epilepsia. 2023;64(12):3354–64. PubMed DOI

Blebea NM, Pricopie AI, Vlad RA, Hancu G. Phytocannabinoids: exploring pharmacological profiles and their impact on therapeutical use. Int J Mol Sci. 2024;25(8):4204. PubMed DOI PMC

Blessing E, Teichmann E, Hinz B. Anandamide inhibits vascular smooth muscle migration, endothelial adhesion protein expression and monocyte adhesion of human coronary artery cells. Cells. 2024;13(24):2108. PubMed DOI PMC

Brann E, Edvinsson A, Rostedt Punga A, Sundstrom-Poromaa I, Skalkidou A. Inflammatory and anti-inflammatory markers in plasma: from late pregnancy to early postpartum. Sci Rep. 2019;9(1):1863. PubMed DOI PMC

Britch SC, Babalonis S, Walsh SL. Cannabidiol: pharmacology and therapeutic targets. Psychopharmacology. 2021;238(1):9–28. PubMed DOI PMC

Carruthers ER, Grimsey NL. Cannabinoid CB(2) receptor orthologues; in vitro function and perspectives for preclinical to clinical translation. Br J Pharmacol. 2024;181(14):2247–69. PubMed DOI

Chatterjee P, Chiasson VL, Bounds KR, Mitchell BM. Regulation of the anti-inflammatory cytokines Interleukin-4 and Interleukin-10 during pregnancy. Front Immunol. 2014;5:253. PubMed DOI PMC

Chen Y, Buck J. Cannabinoids protect cells from oxidative cell death: a receptor-independent mechanism. J Pharmacol Exp Ther. 2000;293(3):807–12. PubMed DOI

Chen H, Liu Y, Yu S, Li C, Gao B, Zhou X. Cannabidiol attenuates periodontal inflammation through inhibiting TLR4/NF-kappaB pathway. J Periodontal Res. 2023;58(4):697–707. PubMed DOI

Chiu V, Leung J, Hall W, Stjepanovic D, Degenhardt L. Public health impacts to date of the legalisation of medical and recreational cannabis use in the USA. Neuropharmacology. 2021;193:108610. PubMed DOI

de Almeida DL, Devi LA. Diversity of molecular targets and signaling pathways for CBD. Pharmacol Res Perspect. 2020;8(6):e00682. PubMed DOI PMC

Di Virgilio F, Vultaggio-Poma V, Falzoni S, Giuliani AL. Extracellular ATP: a powerful inflammatory mediator in the central nervous system. Neuropharmacology. 2023;224:109333. PubMed DOI

Ding J, Maxwell A, Adzibolosu N, Hu A, You Y, Liao A, et al. Mechanisms of immune regulation by the placenta: role of type I interferon and interferon-stimulated genes signaling during pregnancy. Immunol Rev. 2022;308(1):9–24. PubMed DOI PMC

Etemad L, Karimi G, Alavi MS, Roohbakhsh A. Pharmacological effects of cannabidiol by transient receptor potential channels. Life Sci. 2022;300:120582. PubMed DOI

Gesterling L, Bradford H. Cannabis use in pregnancy: a state of the science review. J Midwifery Womens Health. 2022;67(3):305–13. PubMed DOI

Goldstein JA, Gallagher K, Beck C, Kumar R, Gernand AD. Maternal-fetal inflammation in the placenta and the developmental origins of health and disease. Front Immunol. 2020;11:531543. PubMed DOI PMC

Gomez-Chavez F, Correa D, Navarrete-Meneses P, Cancino-Diaz JC, Cancino-Diaz ME, Rodriguez-Martinez S. NF-kappaB and its regulators during pregnancy. Front Immunol. 2021;12:679106. PubMed DOI PMC

Guo Q, Jin Y, Chen X, Ye X, Shen X, Lin M, et al. NF-kappaB in biology and targeted therapy: new insights and translational implications. Signal Transduct Target Ther. 2024;9(1):53. PubMed DOI PMC

Hauguel-de Mouzon S, Guerre-Millo M. The placenta cytokine network and inflammatory signals. Placenta. 2006;27(8):794–8. PubMed DOI

Henshaw FR, Dewsbury LS, Lim CK, Steiner GZ. The effects of cannabinoids on pro- and anti-inflammatory cytokines: a systematic review of in vivo studies. Cannabis Cannabinoid Res. 2021;6(3):177–95. PubMed DOI PMC

Huang X, Luthi M, Ontsouka EC, Kallol S, Baumann MU, Surbek DV, et al. Establishment of a confluent monolayer model with human primary trophoblast cells: novel insights into placental glucose transport. Mol Hum Reprod. 2016;22(6):442–56. PubMed DOI

Iannotti FA, Hill CL, Leo A, Alhusaini A, Soubrane C, Mazzarella E, et al. Nonpsychotropic plant cannabinoids, cannabidivarin (CBDV) and cannabidiol (CBD), activate and desensitize transient receptor potential vanilloid 1 (TRPV1) channels in vitro: potential for the treatment of neuronal hyperexcitability. ACS Chem Neurosci. 2014;5(11):1131–41. PubMed DOI

Ji Z, He L, Regev A, Struhl K. Inflammatory regulatory network mediated by the joint action of NF-kB, STAT3, and AP-1 factors is involved in many human cancers. Proc Natl Acad Sci U S A. 2019;116(19):9453–62. PubMed DOI PMC

Karahoda R, Abad C, Horackova H, Kastner P, Zaugg J, Cerveny L, et al. Dynamics of tryptophan metabolic pathways in human placenta and placental-derived cells: effect of gestation age and trophoblast differentiation. Front Cell Dev Biol. 2020;8:574034. PubMed DOI PMC

Laprairie RB, Bagher AM, Kelly ME, Denovan-Wright EM. Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor. Br J Pharmacol. 2015;172(20):4790–805. PubMed DOI PMC

Liu T, Zhang L, Joo D, Sun SC. NF-kappaB signaling in inflammation. Signal Transduct Target Ther. 2017;2:17023. PubMed DOI PMC

Loganathan P, Gajendran M, Goyal H. A Comprehensive review and update on cannabis hyperemesis syndrome. Pharmaceuticals (Basel). 2024;17(11):1549. PubMed DOI PMC

Martin GI. Marijuana: the effects on pregnancy, the fetus, and the newborn. J Perinatol. 2020;40(10):1470–6. PubMed DOI

Martinez Naya N, Kelly J, Corna G, Golino M, Polizio AH, Abbate A, et al. An overview of cannabidiol as a multifunctional drug: pharmacokinetics and cellular effects. Molecules. 2024;29(2):473. PubMed DOI PMC

Megli CJ, Coyne CB. Infections at the maternal–fetal interface: an overview of pathogenesis and defence. Nat Rev Microbiol. 2022;20(2):67–82. PubMed DOI PMC

Meyyazhagan A, Kuchi Bhotla H, Pappuswamy M, Tsibizova V, Al Qasem M, Di Renzo GC. Cytokine see-saw across pregnancy, its related complexities and consequences. Int J Gynaecol Obstet. 2023;160(2):516–25. PubMed DOI

Moss CG, Dilworth MR, Harris LK, Freeman S, Heazell AEP. Understanding a potential role for the NLRP3 inflammasome in placenta-mediated pregnancy complications. Am J Reprod Immunol. 2025;93(4):e70077. PubMed DOI PMC

Oz M, Yang KS, Mahgoub MO. Effects of cannabinoids on ligand-gated ion channels. Front Physiol. 2022;13:1041833. PubMed DOI PMC

Portillo R, Abad C, Synova T, Kastner P, Heblik D, Kucera R, et al. Cannabidiol disrupts tryptophan metabolism in the human term placenta. Toxicology. 2024;505:153813. PubMed DOI

Rezende B, Alencar AKN, de Bem GF, Fontes-Dantas FL, Montes GC. Endocannabinoid system: chemical characteristics and biological activity. Pharmaceuticals (Basel). 2023;16(2):148. PubMed DOI PMC

Rodrigues FDS, Newton WR, Tassinari ID, da Cunha Xavier FH, Marx A, de Fraga LS, et al. Cannabidiol prevents LPS-induced inflammation by inhibiting the NLRP3 inflammasome and iNOS activity in BV2 microglia cells via CB2 receptors and PPARgamma. Neurochem Int. 2024;177:105769. PubMed DOI

Rokeby ACE, Natale BV, Natale DRC. Cannabinoids and the placenta: receptors, signaling and outcomes. Placenta. 2023;135:51–61. PubMed DOI

Roussos-Ross D, Bright MA, Hill WC. Marijuana and pregnancy: just because its legal doesn’t make it safe. J Perinat Med. 2022;50(9):1277–9. PubMed DOI

Sakai J, Cammarota E, Wright JA, Cicuta P, Gottschalk RA, Li N, et al. Lipopolysaccharide-induced NF-kappaB nuclear translocation is primarily dependent on MyD88, but TNFalpha expression requires TRIF and MyD88. Sci Rep. 2017;7(1):1428. PubMed DOI PMC

Sermet S, Li J, Bach A, Crawford RB, Kaminski NE. Cannabidiol selectively modulates interleukin (IL)-1beta and IL-6 production in toll-like receptor activated human peripheral blood monocytes. Toxicology. 2021;464:153016. PubMed DOI PMC

Soderstrom K, Soliman E, Van Dross R. Cannabinoids modulate neuronal activity and cancer by CB1 and CB2 receptor-independent mechanisms. Front Pharmacol. 2017;8:720. PubMed DOI PMC

Suryavanshi SV, Zaiachuk M, Pryimak N, Kovalchuk I, Kovalchuk O. Cannabinoids alleviate the LPS-induced cytokine storm via attenuating NLRP3 inflammasome signaling and TYK2-mediated STAT3 signaling pathways in vitro. Cells. 2022;11(9):1391. PubMed DOI PMC

Teichmann E, Blessing E, Hinz B. Non-psychoactive phytocannabinoids inhibit inflammation-related changes of human coronary artery smooth muscle and endothelial cells. Cells. 2023;12(19):2389. PubMed DOI PMC

Vachalova V, Karahoda R, Ottaviani M, Anandam KY, Abad C, Albrecht C, et al. Functional reorganization of monoamine transport systems during villous trophoblast differentiation: evidence of distinct differences between primary human trophoblasts and BeWo cells. Reprod Biol Endocrinol. 2022;20(1):112. PubMed DOI PMC

Vornic I, Buciu V, Furau CG, Gaje PN, Ceausu RA, Dumitru CS, et al. Oxidative stress and placental pathogenesis: a contemporary overview of potential biomarkers and emerging therapeutics. Int J Mol Sci. 2024;25(22):12195. PubMed DOI PMC